Quick Answer
STANDARD BIOTOOLS INC. reported Gross Profit of $42.54 million for fiscal year 2025.
STANDARD BIOTOOLS INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $42.54M | -5.2% |
| 2024 | $44.88M | -11.0% |
| 2023 | $50.45M | +36.2% |
| 2022 | $37.05M | -42.4% |
| 2019 | $64.28M | +4.3% |
| 2018 | $61.65M | +18.6% |
| 2017 | $51.98M | -11.0% |
| 2016 | $58.44M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.48M | -21.8% | -10.8% |
| June 30, 2025 | $10.63M | +2.4% | -46.2% |
| March 31, 2025 | $19.74M | -18.4% | +62.8% |
| September 30, 2024 | $12.13M | +8.7% | +16.9% |
| June 30, 2024 | $10.37M | -23.7% | -57.1% |
| March 31, 2024 | $24.19M | +97.0% | +116.9% |
| September 30, 2023 | $11.15M | +21.0% | -18.0% |
| June 30, 2023 | $13.60M | +207.3% | +10.8% |
- STANDARD BIOTOOLS INC. showed a decrease of -5.2% in Gross Profit compared to the prior fiscal year.
- Over the 2016–2025 period, STANDARD BIOTOOLS INC.’s gross profit has declined by 27.2% (from $58.44 million to $42.54 million).
- The most recent figure is from STANDARD BIOTOOLS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: